WEISMAN HOWARD J. (Chief Executive Officer) received a stock award from KUVATRIS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/14/2023ACC: 0001104659-23-045780
DirectorOfficer· Chief Executive Officer
Since Aug 2022
+180K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
180K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+180K
Price / share
—
Trade value
—
% of position
33.2%
4/13/2023
541.63K→721.63K
Total
Net shares
+180K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/13/2023 | A · Award | +180K | — | — | 33.2% | 541.63K | 721.63K |
| Total | +180K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported